Chelation Therapy (Therapy, Chelation)

Subscribe to Selected New Research on Chelation Therapy

587 relevant articles (65 outcomes, 41 trials/studies) found for this Therapy

Description: Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.

Also Known As:

Therapy, Chelation; Chelation Therapies; Therapies, Chelation

Relationship Network

Therapy Context: Research Results

Therapeutics: 5195

Drug Therapy: 116609

Chelation Therapy: 587

Experts

1.	Aessopos, A: 3 articles (10/2005 - 02/2000)
2.	Rofail, Diana: 2 articles (08/2008 - 07/2008)
3.	Gotsis, Efstathios: 2 articles (08/2008 - 12/2004)
4.	Gattermann, Norbert: 2 articles (07/2008 - 12/2007)
5.	Hershko, Chaim: 2 articles (05/2008 - 07/2003)
6.	Cohen, Alan R: 2 articles (01/2008 - 12/2004)
7.	Aessopos, Athanassios: 2 articles (01/2008 - 10/2007)
8.	Tsironi, Maria: 2 articles (01/2008 - 10/2007)
9.	Tsai, Chang-Hai: 2 articles (01/2008 - 01/2006)
10.	Wu, Kang-Hsi: 2 articles (01/2008 - 01/2006)

Related Diseases

1.	Iron Overload 12/01/2001 - "The decrease in iron overload observed in patients on close follow up implies that compliance with chelation therapy has improved with time and therefore, a favourable influence in survival could be expected." 01/01/1999 - "The procedure is safe and effective in reducing iron overload and can obviate the need for chelation therapy, even when the target Hb S is maintained at the standard 30% range." 04/01/1995 - "The ability to quantitate transfusional iron overload is crucial for determining the need for and the efficacy of chelation therapy in patients with long-standing transfusion-dependent anaemias" 01/01/1985 - "Chronic transfusion has become practicable since the recent advances in chelation therapy have essentially eliminated the risk of secondary iron overload." 06/01/2008 - "Frequent blood transfusions can lead to iron overload which may result in several endocrine complications especially in the absence of adequate chelation therapy" Get all the results and reference details, order at left...
2.	beta-Thalassemia (Cooley's Anemia) 02/01/2005 - "Hypertransfusion and regular chelation therapy have allowed improved survival in patients with thalassemia major (TM)" 10/01/2004 - "MATERIALS AND METHODS: All available radiographs and MRI studies of the knees in 14 beta-thalassemia major patients (mean age, 16.3 years; age range, 7-33 years) undergoing chelation therapy with L1 were retrospectively assessed for changes in the synovium, cartilage, and bone" 01/01/1991 - "This study examined anterior pituitary function and the effect of chelation therapy in 31 patients with beta-thalassemia/HbE disease" 01/01/1976 - "A controlled trial of long-term chelation therapy in homozygous beta-thalassemia." 11/01/2006 - "Chelation therapy and bone metabolism markers in thalassemia major." Get all the results and reference details, order at left...
3.	Poisoning 03/01/1984 - "Therefore, it appears that MT does not play an important role in the acute decrease in efficacy of chelation therapy for Cd poisoning" 05/01/1983 - "Therefore, if appears that MT does not have an important role in the acute decrease in efficacy of chelation therapy for Cd poisoning" 02/01/1996 - "Even though there is no doubt that chelation therapy has significantly contributed to reduce mortality and morbidity from occupational Pb poisoning, the efficacy of this treatment in subjects with subtle neurological or renal damage has not yet been studied properly." 07/01/2006 - "In nine patients of poisoning group, CSF-Hg concentrations were correlated with B-Hg (r = 0.675, P < 0.05), but not U-Hg. After chelation therapy with dimercaptopropane sulfonate in five patients of poisoning group, the levels of B-Hg, U-Hg, and CSF-Hg were decreased significantly (P < 0.05)" 07/01/2006 - "In five patients of poisoning group, these concentrations before chelation therapy were compared with those after chelation therapy" Get all the results and reference details, order at left...
4.	Thalassemia 01/01/2008 - "Effects of chelation therapy on cardiac function improvement in thalassemia patients: literature review and the Taiwanese experience." 01/01/2007 - "Severe forms of homozygous thalassemia cases require expensive and technically demanding curative (bone marrow transplantation) or palliative (chronic transfusion/chelation) therapies" 07/01/1995 - "Intravenous chelation therapy during transplantation for thalassemia." 01/01/1995 - "The MR appearance of marrow in thalassemia is a reflection of the patient s transfusion and chelation therapy" 01/01/1995 - "The magnetic resonance bone marrow patterns in thalassemia were evaluated to determine changes produced by transfusion and chelation therapy" Get all the results and reference details, order at left...
5.	Lead Poisoning (Poisoning, Lead) 03/01/1997 - "In summary, LXRF estimates of Pb in tibial cortical bone have yielded highly relevant clinical data relating to the efficacy of chelation therapy with CaNa2EDTA in lead poisoned children; diagnostic approach(es) to childhood lead poisoning; and evaluations of exposure in children, teenagers, and adults in lead-exposed and non-lead-exposed suburban communities" 01/01/1988 - "Two children with lead poisoning had delayed conduction in the peripheral pathways only and in these there was good correlation between the degree of delay and the ulnar nerve conduction velocity; both improved after chelation therapy" 09/01/1991 - "Although both patients improved with several months of intramuscular chelation therapy, the efficacy of such therapy in chronic lead poisoning is controversial" 03/15/2007 - "Two hundred and thirty children were identified with blood lead levels above 10 microg/dL and among these, 80 were provided with medical attention and of eleven who received chelation, six children were desperately ill from acute lead poisoning necessitating repeated sessions of chelation therapy" 01/01/2006 - "Six patients had symptomatic lead poisoning, requiring treatment with chelation therapy" Get all the results and reference details, order at left...
163 Diseases and 587 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Iron (Serum Iron Level)
2.	Deferoxamine (Desferal)
3.	Edetic Acid (EDTA)
4.	Penicillamine (Cuprimine)
5.	deferiprone (CP20)
6.	Succimer (Dimercaptosuccinic Acid)
7.	Dimercaprol (B.A.L.)
8.	Sodium
9.	Aluminum
10.	ethylenediamine (ethylenediamine dihydroiodide)
113 Drugs and Important Bio-Agents and 361 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Splenectomy
2.	Transplantation (Transplant Recipients)
3.	Stents
4.	Transplants (Transplant)
5.	Blood Transfusion (Blood Transfusions)
26 Therapies and Procedures and 64 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>